Autopsy report · NCT02310997
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
Cause of deathSlow enrollment
“Trial closed early due to poor recruitment”
Life of this trial
- Registered 3 years 2 months after it had already started.
- Ran for about 3 years 10 months before it stopped.
- 11 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University College, London
- Sponsor type
- University, hospital or other
- Conditions
- Leukaemia; Lymphoma; Other Haematological Diseases
- Interventions
- Umbilical Cord Blood Transplant; Cyclophosphamide; Total body irradiation; Busulfan; Melphalan; Fludarabine
- Participants
- 11
- Sites
- 12
- Countries
- United Kingdom
Trials that died the same way
- Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
“Poor trial recruitment” - Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
“Due to the low recruitment rate since the start of the trial” - Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke Patients
“The trial was prematurely terminated due to slow recruitment.” - Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation
“The trial is terminated due to the extremely low recruitment rate.” - Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies
“The trial closed early due to slow accrual.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.